top of page

Te hono ki pae. 

Connections across horizons.

Quantifi Photonics is a technology and fabrication company that provides test & measurement instrumentation and bespoke solutions to the optical communications market.

Investment: Series B (2021), Series C (2022)

Zenno Astronautics develop super magnets for space applications that ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.

Investment: Seed (2022)

Visionary. Passionate. Driven.

UBCO Bikes is a vertically-integrated manufacturer of Utility Electric Vehicles (UEV) and battery technologies targeting enterprise and consumer markets.

Investment: Pre Series B x 2 (2021)


EnergyBank is a deep ocean gravitational energy storage company by deploying mass produced floating units (buoys) in deep ocean.

Investment: Seed (2021)

NanoLayr are a global leader in nanofiber technology. They develop scalable high performance functional textiles that improve quality of life.


Investment: Series B (2022) 


Easy Crypto is New Zealand's leading cryptocurrency retail platform. Easy Crypto’s vision is a safe decentralised financial offering for individuals across the world to enhance social equity.

Investment: Series A (2021), Pre Series B (2022)

Interested to learn more?

Copyright © 2022 by Nuance Capital Limited.

Kry10 is developing a secure operating system and platform for mission critical connected devices such as autonomous vehicles, energy and utility infrastructure, or key manufacturing facilities.

Investment: Pre Series A (2023) 

Hectre provides AI-driven technology for growers and packhouses to manage produce from pre to post harvest, allowing produce growers, packers and marketers to reduce waste and optimise their process to increase yield and profits.


Investment: Pre Series A (2023)  

Formus Labs provides AI-powered biomechanical modelling tools to automate pre-operative planning in orthopaedic surgery. The use of Formus’ software results in faster pre-operative planning, faster surgeries, reduced readmissions, and ultimately better patient outcomes.

Investment: Pre Series A (2023)

Our Portfolio Companies

Wellumio is developing a portable MRI device to diagnose stroke. The device will provide fast and accurate life-saving treatment in the ‘golden period’ of stroke, significantly reducing the occurrence of disability and death.

Investment: Seed (2023)

bottom of page